These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26374452)

  • 21. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
    González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
    J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
    Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
    Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
    HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of p16(INK4A) expression of oral squamous cell carcinomas in Taiwan: prognostic correlation without relevance to betel quid consumption.
    Chen YW; Kao SY; Yang MH
    J Surg Oncol; 2012 Aug; 106(2):149-54. PubMed ID: 22354873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma.
    Clatot F; Picquenot JM; Choussy O; Gouérant S; Moldovan C; Schultheis D; Cornic M; François A; Blot E; Laberge-Le-Couteulx S
    Oral Oncol; 2011 Nov; 47(11):1062-8. PubMed ID: 21840752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.
    Tribius S; Hoffmann AS; Bastrop S; Görögh T; Haag J; Röcken C; Clauditz T; Grob T; Wilczak W; Tennstedt P; Borcherding A; Petersen C; Hoffmann M
    Oral Oncol; 2012 Nov; 48(11):1178-84. PubMed ID: 22739067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum CXCL12, but not CXCR4, Is Associated with Head and Neck Squamous Cell Carcinomas.
    Lavaee F; Zare S; Mojtahedi Z; Malekzadeh M; Khademi B; Ghaderi A
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):901-904. PubMed ID: 29693336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
    Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M
    Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
    Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
    J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
    Clatot F; Gouérant S; Mareschal S; Cornic M; Berghian A; Choussy O; El Ouakif F; François A; Bénard M; Ruminy P; Picquenot JM; Jardin F
    Oral Oncol; 2014 Mar; 50(3):200-7. PubMed ID: 24387976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma.
    Faber A; Goessler UR; Hoermann K; Schultz JD; Umbreit C; Stern-Straeter J
    Oncol Rep; 2013 Jun; 29(6):2325-31. PubMed ID: 23563306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Translational research in head and neck cancer. Biological characteristics and general aspects].
    Dietz A; Wichmann G
    HNO; 2011 Sep; 59(9):874-84. PubMed ID: 21861150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
    van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
    Samara GJ; Lawrence DM; Chiarelli CJ; Valentino MD; Lyubsky S; Zucker S; Vaday GG
    Cancer Lett; 2004 Oct; 214(2):231-41. PubMed ID: 15363550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
    Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV
    Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.
    Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z
    Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.